The National Institute on Aging and Alzheimer’s Association unified the diagnostic recommendations for AD by recognizing beta-amyloid and neurofibrillary tau deposits as unique entities that define this distinct neurodegenerative disease [5]. Here, MAPT is linked to Alzheimer disease.